Finnish Institute for Health and Welfare, later referred to as THL or Customer, is about to publish a call for tenders for "Antibacterials, antimycobacterials and antimycotics for systemic use, part 2.". The date of publication of the call for tenders is planned for November 2024.

The scope of procurement is described in more detail in Annex 1. The procurement will be divided in eight (8) lots. Each product constitutes a separate lot. Tender may be submitted for one or several lots.

LOT 1: Ertapenem 1 g (1 g powder for i.v. / vial, ATC J01DH03)

LOT 2: Cefiderocol 1 g (1 g powder for i.v. / vial, ATC J01DI04)

LOT 3: Clindamycin 150 mg/ml (4 ml per vial/ampoule, ATC J01FF01)

LOT 4: Levofloxacin 5 mg/ml (100 ml, i.v. solution, ATC J01MA12)

LOT 5: Piperacillin tatzobactam 4 g/0,5 g (4 g/0,5 g powder for i.v. / vial, ATC J01CR05)

LOT 6: Ceftriaxone natrium 2 g (2 g powder for i.v. / vial, ATC J01DD04)

LOT 7: Fluconazole 2 mg/ml (100 ml, i.v. solution, ATC J02AC01)

LOT 8: Rifampicin 300 mg or 600 mg (tablet/capsule, oral, ATC J04AB02)

The minimum requirements for the products is described in Annex 1.1.

The contract will be awarded to one supplier for each lot based on a comparison of tenders.

Estimated quantity for the products is described in Annex 1.2 (restricted to security classification level IV, TL IV). In addition to the estimated quantity indicated in the Annex 1.2, the Customer is entitled to purchase 100 % extra to the estimated quantities (later referred as "Option"). The supplier is not obliged to deliver the products under the Option.

THL reserves the right to change the scope of the procurement and the minimum requirements in the published call for tenders.